Czech Clinical Research Infrastructure Network

CZECRIN (Czech Clinical Research Infrastructure Network) is the Czech national node of the pan-European ECRIN-ERIC research infrastructure, supporting non-commercial academic clinical trials across Czech hospitals and research institutions. It has actively showcased the PSIKET001 and PSIKET002 trials — landmark double-blind comparisons of psilocybin versus ketamine for treatment-resistant depression at the National Institute of Mental Health — as flagship examples of Czech psychedelic clinical innovation.